Site Search

Displaying results 461 - 470 of 893

‘We made significant accomplishments in a very challenging field’ – an interview with MIP-DILI project coordinators

News | 09/04/2018 |

Success stories from projects

IMI’s MIP-DILI project deepened the knowledge of the science behind drug-induced liver injury (DILI) and improved laboratory tests in use to predict DILI in the early stages of drug development. In an interview with the IMI Programme Office, Richard Weaver of Servier and academic ...

Patients are already benefiting from our project – an interview with the OncoTrack coordinators

News | 05/04/2018 |

Success stories from projects

IMI’s OncoTrack project developed colon cancer models which allow researchers to more accurately predict the effect of drugs on different types of colon cancer tumours. This and other project outputs are already helping some doctors in choosing the right drug for the right ...

77th edition - March 2018

Newsletter Issue | March 2018

Table of contents:

IMI at BIO 2018

Event | 04/06/2018 - 07/06/2018 | Boston, US

IMI took part in the 2018 BIO International Convention which was held in Boston, US on 4-7 June inclusive. IMI session: ‘Will public-private partnerships take the leap into open science?’ Tuesday 5 June, 11:00 | Room 252AB, Level 2 | Session ID 19842 IMI organised a session in ...

‘EUPATI has been a game-changer in the empowerment of patients’ – an interview with the project coordinators

News | 20/03/2018 |

Success stories from projects

EUPATI built a much-needed programme for patient involvement in medicines research and development, and has been a game changer for patient empowerment in Europe, building a movement that will long outlive the project itself. In an interview with the IMI Programme Office, project ...

IMI2 - Call 14

Content | 15/03/2018

IMI2 – Call 14 was launched on 15 March 2018 with the following topics: Targeted immune intervention for the management of non-response and relapse Non-invasive clinical molecular imaging of immune cells Development of a platform for federated and privacy-preserving machine ...

Immune diseases and machine learning feature in new IMI Call for proposals

News | 15/03/2018 |

Press releases

Brussels, Belgium, 15 March 2018 – Today, the Innovative Medicines Initiative (IMI) is launching a new EUR 82 million Call for proposals focusing on immune diseases, imaging, machine learning, and digital clinical trials.

BD4BO

Project| Ongoing | IMI2 |
Cardiovascular diseases
Neurodegenerative diseases
Cancer
Alzheimer's disease
BD4BO
Patient involvement in R&D
Big data and knowledge management
Real-world data, evidence

Big Data for Better Outcomes

‘The more you put in, the more you get out’ – an interview with Katharine Briggs, Lhasa Limited

News | 12/03/2018 |

Testimonials

Lhasa Limited specialises in the development of in silico (computer-based) systems for use in research on toxicology, metabolism and related sciences. The company has just over 150 employees and is headquartered in Leeds, UK with additional offices in Newcastle (UK) and Poznan ...

Joint declaration on harassment

News | 08/03/2018 |

Press releases

Together, we the Heads of EU agencies and Joint undertakings commit to zero tolerance towards sexual harassment and we cannot and will not accept harassment of any form in our agencies. We take it upon ourselves to communicate to our staff that harassment in the workplace is ...